These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34532976)

  • 1. Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.
    Wan J; Vadaq N; Konings J; Jaeger M; Kumar V; de Laat B; Joosten L; Netea MG; van der Ven AJ; de Groot PG; de Mast Q; Roest M
    J Thromb Haemost; 2022 Jan; 20(1):48-57. PubMed ID: 34532976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T; Sugiyama N; Morishima Y; Shibano T
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Gly197 in the structure and function of protein C.
    Lu Y; Biswas I; Villoutreix BO; Rezaie AR
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129892. PubMed ID: 33722640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
    Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
    Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
    Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
    De Smedt E; Wagenvoord R; Coen Hemker H
    Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
    Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O
    Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo.
    Perzborn E; Heitmeier S; Buetehorn U; Laux V
    J Thromb Haemost; 2014 Jul; 12(7):1054-65. PubMed ID: 24766850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
    Navarro S; Medina P; Bonet E; Corral J; Martínez-Sales V; Martos L; Rivera M; Roselló-Lletí E; Alberca I; Roldán V; Mira Y; Ferrando F; Estellés A; Vicente V; Bertina RM; España F
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1435-40. PubMed ID: 23520161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.
    Ammollo CT; Semeraro F; Xu J; Esmon NL; Esmon CT
    J Thromb Haemost; 2011 Sep; 9(9):1795-803. PubMed ID: 21711444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin.
    Tarandovskiy ID; Buehler PW; Ataullakhanov FI; Karnaukhova E
    Thromb Res; 2019 Apr; 176():54-60. PubMed ID: 30784776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
    J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.
    Cvirn G; Gallistl S; Rehak T; Jürgens G; Muntean W
    J Thromb Haemost; 2003 Aug; 1(8):1785-90. PubMed ID: 12911594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index.
    Mohamed ABO; Kelchtermans H; Konings J; van Daal J; Al Marzouki A; Harakeh S; de Laat B
    PLoS One; 2018; 13(10):e0206376. PubMed ID: 30359453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin.
    Furugohri T; Morishima Y
    Thromb Res; 2015 Sep; 136(3):658-62. PubMed ID: 26188924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.